This study states that Racial inequality remains a considerable problem in society worldwide. For Black and African‐American individuals, it is a sobering and painful reality that has persisted for almost six decades since the Civil Rights Act was passed in 1964. However, in recent months, a rising crescendo of protest against racial discrimination has emerged in the United States and internationally. It has become a modern‐day social renaissance, not only seeking to bridge the gap between races but also to rediscover and recognize previously neglected Black, Asian and minority ethnic (BAME) influences in society.
Medicine is no exception: The role of BAME physicians in pioneering disease research is rich but relatively under‐recognized in modern medical literature. Dr Solomon Carter Fuller, the focus of this article, is widely acknowledged as the first African‐American psychiatrist and, alongside his contemporary Alois Alzheimer, a trailblazer of dementia research. Yet at the time of writing (August 4, 2020), a simple PubMed search for “Solomon Carter Fuller” or “Solomon Fuller” in the “Title” field yielded a mere 2 results, compared with 41 when replaced with “Alois Alzheimer.”
Hence we conclude that By delving into his life, experiences, and contributions to neurology, this brief biography seeks to unravel the obscurity that has veiled the accomplishments of Solomon Carter Fuller in Alzheimer’s disease.
Reference link- https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.12183
